Cardiac biomarkers and prediction of ESRD

American Journal of Kidney Diseases

Volumn 58, Issue 5, 2011, Pages 689-691

  Nicholas, Susanne B ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; HEMOGLOBIN; TRANSFERRIN; TROPONIN T;

ACUTE KIDNEY FAILURE; ANEMIA; CHRONIC KIDNEY FAILURE; EDITORIAL; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; PREDICTION;

ANEMIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; TROPONIN T;

EID: 80055017095     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.08.013     Document Type: Editorial

References (17)

1. Biomarkers Definition Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 69 2001 89 95
2. K. Matsushita, M. van der Velde, and B.C. Astor Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2010 2073 2081
3. A.S. Levey, L.A. Stevens, and J. Coresh Conceptual model of CKD: applications and implications Am J Kidney Dis 53 suppl 3 2009 S4 S16
4. C. Ronco, M. Haapio, A.A. House, N. Anavekar, and R. Bellomo Cardiorenal syndrome J Am Coll Cardiol 52 2008 1527 1539
5. E.F. Elsayed, H. Tighiouart, and J. Griffith Cardiovascular disease and subsequent kidney disease Arch Intern Med 167 2007 1130 1136 (Pubitemid 46919815)
6. C. Ronco, D. Cruz, and R. Bellomo Continuous renal replacement in critical illness Contrib Nephrol 156 2007 309 319
7. S.G. Coca, B. Yusuf, M.G. Shlipak, A.X. Garg, and C.R. Parikh Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis Am J Kidney Dis 53 2009 961 973
8. A.S. Desai, R. Toto, and P. Jarolim Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD Am J Kidney Dis 58 5 2011 717 728
9. W.F. Keane, Z. Zhang, and P.A. Lyle Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL Study Clin J Am Soc Nephrol 1 2006 761 767
10. M.A. Pfeffer, E.A. Burdmann, and C.Y. Chen Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Am J Kidney Dis 54 2009 59 69
11. M.J. Landray, J.R. Emberson, and L. Blackwell Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study Am J Kidney Dis 56 2010 1082 1094
12. A. Al-Hweish, S.S. Sultan, K. Mogazi, and M.Y. Elsammak Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis Hemodial Int 14 2010 308 315
13. O. Ortega, I. Rodriguez, and C. Gracia Strict volume control and longitudinal changes in cardiac biomarker levels in hemodialysis patients Nephron Clin Pract 113 2009 c96 c103
14. M.A. Roberts, A.J. Hedley, and F.L. Ierino Understanding cardiac biomarkers in end-stage kidney disease: frequently asked questions and the promise of clinical application Nephrology (Carlton) 16 2011 251 260
15. D.S. Keith, G.A. Nichols, C.M. Gullion, J.B. Brown, and D.H. Smith Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 2004 659 663 (Pubitemid 38392981)
16. S. Manzano-Fernandez, M. Boronat-Garcia, and M.D. Albaladejo-Oton Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure Am J Cardiol 103 2009 1753 1759
17. A.H. Wu, A.S. Jaffe, and F.S. Apple National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure Clin Chem 53 2007 208620 208696